B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors.

B7-H3 CAR-T acute myeloid leukemia chimeric antigen receptor melanoma

Journal

Molecular therapy oncolytics
ISSN: 2372-7705
Titre abrégé: Mol Ther Oncolytics
Pays: United States
ID NLM: 101666776

Informations de publication

Date de publication:
26 Jun 2020
Historique:
received: 05 03 2020
accepted: 27 03 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 30 4 2020
Statut: epublish

Résumé

Recently, B7-H3 was frequently reported to be overexpressed in various cancer types and has been suggested to be a promising target for cancer immunotherapy. In the present study, we analyzed the mRNA expression of B7-H3 in The Cancer Genome Atlas (TCGA) database and validated its expression across multiple cancer types. We then generated a novel B7-H3-targeted chimeric antigen receptor (CAR) and tested its antitumor activity both

Identifiants

pubmed: 32346608
doi: 10.1016/j.omto.2020.03.019
pii: S2372-7705(20)30044-9
pmc: PMC7178328
doi:

Types de publication

Journal Article

Langues

eng

Pagination

180-189

Informations de copyright

© 2020 The Author(s).

Références

Lancet Oncol. 2018 Aug;19(8):1040-1050
pubmed: 29914796
J Immunol Methods. 2009 Feb 28;341(1-2):86-96
pubmed: 19041872
Mol Ther. 2010 Apr;18(4):843-51
pubmed: 20179677
Blood. 2015 May 21;125(21):3335-46
pubmed: 25814530
J Immunol. 2004 Feb 15;172(4):2352-9
pubmed: 14764704
Cell Res. 2017 Aug;27(8):1034-1045
pubmed: 28685773
Cancer Cell. 2017 Apr 10;31(4):501-515.e8
pubmed: 28399408
Cell Res. 2017 Jan;27(1):38-58
pubmed: 28025979
J Neurooncol. 2010 May;97(3):409-18
pubmed: 19890606
Lung Cancer. 2017 Jan;103:44-51
pubmed: 28024695
EBioMedicine. 2019 Sep;47:33-43
pubmed: 31466914
Nat Immunol. 2001 Mar;2(3):269-74
pubmed: 11224528
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10277-8
pubmed: 18650376
Cancer Med. 2015 Dec;4(12):1879-83
pubmed: 26376842
Mol Ther Oncolytics. 2019 Jul 23;14:279-287
pubmed: 31485480
Front Immunol. 2019 Apr 17;10:780
pubmed: 31049049
Cancer Cell. 2019 Feb 11;35(2):221-237.e8
pubmed: 30753824
Sci Transl Med. 2017 Jul 19;9(399):
pubmed: 28724573
Clin Cancer Res. 2019 Apr 15;25(8):2560-2574
pubmed: 30655315
Cancer Discov. 2013 Apr;3(4):388-98
pubmed: 23550147
Blood. 2003 Mar 1;101(5):1905-12
pubmed: 12411306
Science. 2015 Apr 3;348(6230):62-8
pubmed: 25838374
J Immunol. 2004 Aug 15;173(4):2500-6
pubmed: 15294965
Nat Immunol. 2003 Sep;4(9):899-906
pubmed: 12925852

Auteurs

Zongliang Zhang (Z)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Caiying Jiang (C)

Life Science and Clinical Research Center, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.

Zhiyong Liu (Z)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Meijia Yang (M)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Xin Tang (X)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Yuelong Wang (Y)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Meijun Zheng (M)

Department of Otolaryngology, Head and Neck Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Jianhan Huang (J)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Kunhong Zhong (K)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Shasha Zhao (S)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Mei Tang (M)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Tingyue Zhou (T)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Hui Yang (H)

Department of Otolaryngology, Head and Neck Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Gang Guo (G)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Liangxue Zhou (L)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Jianguo Xu (J)

Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Aiping Tong (A)

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Classifications MeSH